Skip to content

Lipids for Little Ones (W32)

Jan 24 | 2:30PM - 4:00PM

Lipids for Little Ones (W32)


  1. Describe the theoretical and published clinical benefits of incorporating MCT, OO and/or FO into SO-based IVLE for pediatric PN
  2. Examine case studies from international centers that have successfully used the newer IVLE for pediatric PN
  3. Choose between the different IVLE when formulating a PN regimen for optimum nutrition support for improved pediatric patient outcome


Australian and European Practical Experiences with IVLE in Pediatric Parenteral Nutrition
Theodoric Wong, BMedSc, MBBS,  FRACP

Current Evidence for Improvements in Cholestasis, Liver Function, and Retinopathy of Prematurity with Alternative IVLE
Gil Hardy, PhD, FRCS, FASPEN

FO-Containing IVLE in Critically Ill Infants: Current Evidence and Clinical Outcomes
Adrienne Speedy, RD


Michael Chourdakis, MD, RD, MPH, PhD

Jesus Velazquez, MD

LEARNING LEVEL: Intermediate
UAN: J0002345-0000-18-028-L04-P
CE CREDIT: 1.5 hours

Presented by the ASPEN International Clinical Ethics Section and ASPEN Ibero-Latin American Section (ILAS)